BMO Capital raised the firm’s price target on Healthcare Services (HCSG) to $22 from $20 and keeps a Market Perform rating on the shares. Q4 revenue was in line but adjusted EBITDA beat consensus by 22% on stronger than expected margins, as the company guided to mid-single-digit 2026 revenue growth following 7% in 2025, driven by improved earnings consistency, better cash collections, and momentum in the Campuses end-market, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCSG:
